Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution: Clinical article

Journal of Neurosurgery

Volumn 115, Issue 2, 2011, Pages 220-229

  Marina, Ovidiu ^a,b   Suh, John H ^b   Reddy, Chandana A ^b   Barnett, Gene H ^b   Vogelbaum, Michael A ^b   Peereboom, David M ^b   Stevens, Glen H J ^b,c   Elinzano, Heinrich ^c   Chao, Samuel T ^b  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Brain; Central nervous system; Glioblastoma multiforme; Oncology; Palliative therapy; Poor functional status; Poor prognostic factor

Indexed keywords

CARBOPLATIN; CARMUSTINE; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TERTIARY HEALTH CARE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79961124087     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2011.3.JNS10495     Document Type: Article

References (27)

1. Barker FG II, Chang SM, Larson DA, Sneed PK, Wara WM, Wilson CB, et al: Age and radiation response in glioblastoma multiforme. Neurosurgery 49:1288-1298, 2001 (Pubitemid 34215161)
2. Bauman GS, Gaspar LE, Fisher BJ, Halperin EC, Macdonald DR, Cairncross JG: A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 29:835-839, 1994 (Pubitemid 24241325)
3. Bleehen NM, Stenning SP: A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br J Cancer 64:769-774, 1991
4. Brandes AA, Vastola F, Basso U, Berti F, Pinna G, Rotilio A, et al: A prospective study on glioblastoma in the elderly. Cancer 97:657-662, 2003 (Pubitemid 36125843)
5. Chamberlain MC: Treatment options for glioblastoma. Neurosurg Focus 20(4):E19, 2006
6. Chang EL, Yi W, Allen PK, Levin VA, Sawaya RE, Maor MH: Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: outcome and prognostic factors. Int J Radiat Oncol Biol Phys 56:519-528, 2003 (Pubitemid 36542912)
7. Combs SE, Wagner J, Bischof M, Welzel T, Wagner F, Debus J, et al: Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int J Radiat Oncol Biol Phys 70:987-992, 2008 (Pubitemid 351296114)
8. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704-710, 1993 (Pubitemid 23133591)
9. Ducray F, Benouaich-Amiel A, Idbaih A, Rousseau A, Laigle-Donadey F, Delattre JY, et al: Complete response after one cycle of temozolomide in an elderly patient with glioblastoma and poor performance status. J Neurooncol 88:185-188, 2008
10. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997-1003, 2005 (Pubitemid 40349502)
11. Hernandez JC, Maruyama Y, Yaes R, Chin HW: Accelerated fractionation radiotherapy for hospitalized glioblastoma multiforme patients with poor prognostic factors. J Neurooncol 9:41-45, 1990 (Pubitemid 20250794)
12. Ino Y, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Jhung S, et al: Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. J Neurosurg 92:983-990, 2000 (Pubitemid 30346517)
13. Jeremic B, Shibamoto Y, Grujicic D, Milicic B, Stojanovic M, Nikolic N, et al: Short-course radiotherapy in elderly and frail patients with glioblastoma multiforme. A phase II study. J Neurooncol 44:85-90, 1999 (Pubitemid 29515655)
14. Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, et al: Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527-1535, 2007 (Pubitemid 46588417)
15. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, et al: Long-term survival with glioblastoma multiforme. Brain 130:2596-2606, 2007 (Pubitemid 47511715)
16. Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, et al: Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol 24:2563-2569, 2006 (Pubitemid 46630635)
17. Mohan DS, Suh JH, Phan JL, Kupelian PA, Cohen BH, Barnett GH: Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys 42:981-987, 1998 (Pubitemid 29004138)
18. Muni R, Minniti G, Lanzetta G, Caporello P, Frati A, Enrici MM, et al: Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma. Tumori 96:60-64, 2010
19. Pichlmeier U, Bink A, Schackert G, Stummer W: Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10:1025-1034, 2008
20. Roa W, Brasher PM, Bauman G, Anthes M, Bruera E, Chan A, et al: Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22:1583-1588, 2004 (Pubitemid 41079795)
21. Salmaggi A, Silvani A, Merli R, Caroli M, Tomei G, Russo A, et al: Multicentre prospective collection of newly diagnosed glioblastoma patients: update on the Lombardia experience. Neurol Sci 29:77-83, 2008 (Pubitemid 351696408)
22. Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, Iturria N, et al: PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 93:1246-1256, 2001 (Pubitemid 32816199)
23. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005 (Pubitemid 40349501)
24. Thomas R, James N, Guerrero D, Ashley S, Gregor A, Brada M: Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol 33:113-116, 1994
25. Villà S, Viñolas N, Verger E, Yaya R, Martínez A, Gil M, et al: Efficacy of radiotherapy for malignant gliomas in elderly patients. Int J Radiat Oncol Biol Phys 42:977-980, 1998 (Pubitemid 29004137)
26. Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH, et al: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323-1329, 1980 (Pubitemid 11194457)
27. Walker MD, Strike TA, Sheline GE: An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5:1725-1731, 1979 (Pubitemid 10187518)